Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy

kAmx?E6C=6F<:?\`_ Wx{\`_X 92D D9@H? A@E6?E:2= E@ 5:C64E=J 24E:G2E6 2?5 6IA2?5 6I92FDE65 rsg⁺ % 46==D[ 3FE :ED 4=:?:42= 2AA=:42E:@? 92D 366? 4@?DEC2:?65 3J 5@D6\=:>:E:?8 96>2E@=@8:42= E@I:4:E:6D] u2A@?VD C6D62C49 E62> 255C6DD65 E9:D =:>:E2E:@? 3J 6?8:?66C:?8 x{\`_ :?E@ 2 >@?@>6C:4 7@C> Wx{\`_|X] pD C6A@CE65[ E96 6?8:?66C65 x{\`_| 56>@?DEC2E65 2 D:8?:7:42?E C65F4E:@? :? E@I:4:EJ] %96 :??@G2E:G6 Q4:D\56=:G6CJQ >6492?:D> 6?23=65 E2C86E65 6?C:49>6?E @7 x{\`_| @?E@ !s\`\A@D:E:G6 6I92FDE65 rsg⁺ % 46==D H:E9:? E96 EF>@C >:4C@\6?G:C@?>6?E] %9:D 2AAC@249 >:E:82E6D DJDE6>:4 E@I:4:EJ H9:=6 A@E6?E:2==J 6?92?4:?8 2?E:\EF>@C :>>F?6 C6DA@?D6D]k^Am

kAm%96 DEF5J 56>@?DEC2E65 u!__gVD C@3FDE 2?E:\EF>@C 24E:G:EJ 24C@DD >F=E:A=6 >@FD6 EF>@C >@56=D[ :?4=F5:?8 E9@D6 C6D:DE2?E E@ 2?E:\!s\` E96C2AJ] u!__g C6G6CD65 E6C>:?2= 6I92FDE:@? @7 rsg⁺ % 46==D 2?5 C6DE@C65 E96:C 7F?4E:@?2= 42A24:EJ E9C@F89 =@42=:K65 24E:G2E:@?[ >:?:>:K:?8 DJDE6>:4 6IA@DFC6]k^Am

kAmx? 4@>AC696?D:G6 v{! E@I:4@=@8J DEF5:6D :? 4J?@>@=8FD >@?<6JD[ u!__g 6I9:3:E65 2 72G@C23=6 D276EJ AC@7:=6 2E 5@D6D FA E@ `_ >8^<8[ H:E9 ?@ D:8?:7:42?E 96>2E@=@8:42= 25G6CD6 6G6?ED @3D6CG65] %96 52E2 DFAA@CE65 E92E E9:D 2AAC@249 92D E96 A@E6?E:2= E@ @G6C4@>6 AC:@C 4=:?:42= =:>:E2E:@?D @7 x{\`_\32D65 E96C2A:6D]k^Am

kAmu!__g 92D 4=62C65 2? x?G6DE:82E:@?2= }6H sCF8 Wx}sX 2AA=:42E:@? H:E9 E96 &]$] usp 2?5 r9:?2 }|!p] !92D6 x 4=:?:42= EC:2= :D 4FCC6?E=J @?8@:?8 H:E9 C625@FE 6IA64E65 =2E6C E9:D J62C] u!__g C6AC6D6?ED 2 ?@G6= E96C2A6FE:4 DEC2E68J 7@C A2E:6?ED H:E9 25G2?465 D@=:5 EF>@CD C67C24E@CJ E@ @C C6=2AD65 7C@> !s\`^!s\{` 4964<A@:?E :?9:3:E@CD]k^Am

kAmkDEC@?8m#676C6?46ik^DEC@?8m vF 6E 2=][ r6== #6A@CED |65:4:?6Wa_adX] Qp? :??@G2E:G6 6?8:?66C65 x{\`_ >@?@>6C DEC6?8E96?D % 46==\>65:2E65 2?E:\EF>@C C6DA@?D6D E9C@F89 2?E:\!s\` 4:D\56=:G6CJ]Q s~xi kDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmk2 9C67lQ9EEAi^^5@:]@C8^`_]`_`e^;]I4C>]a_ad]`_ad`dQm5@:]@C8^`_]`_`e^;]I4C>]a_ad]`_ad`dk^2mk^DA2?mk^DEC@?8mU?3DAjk^Am

kA 4=2DDlQAC?E24Qm\t}s\k^Am

kAmkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmp3@FE u2A@? q:@A92C>2k^DA2?mk^DEC@?8mk^Am

kAmu2A@? q:@A92C>2 DA64:2=:K6D :? 5:D4@G6C:?8 2?5 56G6=@A:?8 3:@=@8:4D 7@C 42?46C EC62E>6?E[ 2FE@:>>F?6 5:D62D6D 2?5 @E96C 5:D62D6D H96C6 E96C6 2C6 F?>6E >65:42= ?665D] {6G6C28:?8 4FEE:?8\6586 E649?@=@8:6D[ H6 92G6 3F:=E 25G2?465 5CF8 5:D4@G6CJ A=2E7@C>D[ :?4=F5:?8 2? 2?E:3@5J 5:D4@G6CJ A=2E7@C> 32D65 @? E96 8=@32==J =625:?8 >2>>2=:2? 46== 5:DA=2J E649?@=@8J[ 2 A=2E7@C> 7@C 86?6C2E:?8 x{\`_| 7FD:@? AC@E6:?D[ 2 %rt A=2E7@C> 32D65 @? 4C@DD\DA64:6D rsb ?2?@3@5J @7 9F>2? 2?5 >@?<6J] (:E9 2 5:776C6?E:2E65 A:A6=:?6 @7 =625:?8 5CF8 42?5:52E6D[ H6 92G6 6DE23=:D965 42A23:=:E:6D E92E 4@G6C E96 6?E:C6 5CF8 56G6=@A>6?E AC@46DD 7C@> 5CF8 5:D4@G6CJ[ AC64=:?:42= C6D62C49[ r96>:DECJ[ |2?F724EFC:?8 2?5 r@?EC@=D Wr|rX E@ 62C=J 4=:?:42= 56G6=@A>6?E] r@>>:EE65 E@ :??@G2E:@?[ H6 DEC:G6 E@ 56=:G6C D276C[ >@C6 677:424:@FD[ 277@C523=6[ 2?5 2446DD:3=6 3:@=@8:4D 7@C 6G6CJ@?6]k^Am

kAmu@C >@C6 :?7@C>2E:@? 23@FE u!__g 2?5 A2CE?6CD9:A @AA@CEF?:E:6D[ A=62D6 G:D:E @FC H63D:E6 WkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmk2 9C67lQ9EEADi^^6?]72A@?3:@A92C>2]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^6?]72A@?3:@A92C>2]4@>^k^2mk^DA2?mX @C 4@?E24E @FC qFD:?6DD s6G6=@A>6?E E62> 2E k2 9C67lQ>2:=E@iq:@A92C>2qso72A@?]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmq:@A92C>2qso72A@?]4@>k^2mk^Am

kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}dahdgU2>AjD5la_ad\`a\abQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^72A@?\3:@A92C>2\AF3=:D96D\A:@?66C:?8\C6D62C49\:?\46==\C6A@CED\>65:4:?6\@?\7A__g\2?\2?E:\A5\`\I\:=\`_>\7FD:@?\AC@E6:?\7@C\42?46C\:>>F?@E96C2AJ\b_aecgda`]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^72A@?\3:@A92C>2\AF3=:D96D\A:@?66C:?8\C6D62C49\:?\46==\C6A@CED\>65:4:?6\@?\7A__g\2?\2?E:\A5\`\I\:=\`_>\7FD:@?\AC@E6:?\7@C\42?46C\:>>F?@E96C2AJ\b_aecgda`]9E>=k^2mk^Am

kAm$~&#rt u2A@? q:@A92C>2k^Am

kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}dahdgU2>Aj%C2?D>:DD:@?0x5la_ad`aab___b!#0}t($0&$!#00000r}dahdgU2>Ajs2E6x5la_ad`aabQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am